Connection
Marc Bonaca to Incretins
This is a "connection" page, showing publications Marc Bonaca has written about Incretins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.939 |
|
|
|
-
Bonaca MP, Catarig AM, Hansen Y, Houlind K, Ramesh CK, Ludvik B, Nordanstig J, Rasouli N, Sourij H, Verma S. Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes. Eur Heart J Cardiovasc Pharmacother. 2025 Jan 11; 10(8):728-737.
Score: 0.939